Redoxis
Pre-clinicalRedoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of autoimmune disease. With the roots in academic research we are continuously updating our portfolio of models.
Founded
2009
Focus
ImmunologyRare Disease
About
Redoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of autoimmune disease. With the roots in academic research we are continuously updating our portfolio of models.
Funding History
3Total raised: $16M
Series A$12MIndustrifondenNov 15, 2022
Seed$3.2MChalmers VenturesSep 15, 2020
Grant$800KVinnovaJun 15, 2019
Company Info
TypePrivate
Founded2009
LocationGothenburg, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile